Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors

被引:49
作者
Burmistrov, Vladimir [2 ,3 ]
Morisseau, Christophe [1 ]
Lee, Kin Sing Stephen [1 ]
Shihadih, Diyala S. [1 ]
Harris, Todd R. [1 ]
Butov, Gennady M. [2 ,3 ]
Hammock, Bruce D. [1 ]
机构
[1] Univ Calif Davis, Ctr Comprehens Canc, Dept Entomol & Nematol, Davis, CA 95616 USA
[2] Volgograd State Tech Univ, Volzhsky Polytech Inst Branch, Dept Chem & Gen Chem Technol, Volzhsky, Russia
[3] Volgograd State Tech Univ, Volgograd, Russia
基金
俄罗斯基础研究基金会;
关键词
Soluble epoxide hydrolase; Inhibitor; Adamantane; Isocyanate; Diurea; EPOXYEICOSATRIENOIC ACIDS; WATER SOLUBILITY; BLOOD-PRESSURE; UREA; HYPERTENSION; HYDROLYSIS; MECHANISM; DISCOVERY;
D O I
10.1016/j.bmcl.2014.03.016
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of inhibitors of the soluble epoxide hydrolase (sEH) containing two urea groups has been developed. Inhibition potency of the described compounds ranges from 2.0 mu M to 0.4 nM. 1,6-(Hexamethylene)bis[(adamant-1-yl) urea] (3b) was found to be a potent slow tight binding inhibitor (IC50 = 0.5 nM) with a strong binding to sEH (K-i = 3.1 nM) and a moderately long residence time on the enzyme (k(off) = 1.05 x 10(-3) s(-1); t(1/2) = 11 min). (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2193 / 2197
页数:5
相关论文
共 29 条
[11]   Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension [J].
Kato, Yuko ;
Fuchi, Nobuhiro ;
Saburi, Hajime ;
Nishimura, Yutaka ;
Watanabe, Ayano ;
Yagi, Mai ;
Nakadera, Yasuhito ;
Higashi, Eriko ;
Yamada, Masateru ;
Aoki, Takumi .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (21) :5975-5979
[12]   Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility [J].
Kim, IH ;
Heirtzler, FR ;
Morisseau, C ;
Nishi, K ;
Tsai, HJ ;
Hammock, BD .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (10) :3621-3629
[13]   Design, synthesis, and biological activity of 1,3-Disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility [J].
Kim, IH ;
Morisseau, C ;
Watanabe, T ;
Hammock, BD .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (08) :2110-2122
[14]   Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method [J].
Kowalski, Jennifer A. ;
Swinamer, Alan D. ;
Muegge, Ingo ;
Eldrup, Anne B. ;
Kukulka, Alison ;
Cywin, Charles L. ;
De Lombaert, Stephane .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) :3703-3707
[15]   Forster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase [J].
Lee, Kin Sing Stephen ;
Morisseau, Christophe ;
Yang, Jun ;
Wang, Peng ;
Hwang, Sung Hee ;
Hammock, Bruce D. .
ANALYTICAL BIOCHEMISTRY, 2013, 434 (02) :259-268
[16]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997) [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :3-26
[17]   QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds [J].
McElroy, NR ;
Jurs, PC ;
Morisseau, C ;
Hammock, BD .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) :1066-1080
[18]   A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening [J].
McGovern, SL ;
Caselli, E ;
Grigorieff, N ;
Shoichet, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) :1712-1722
[19]   Potent urea and carbamate inhibitors of soluble epoxide hydrolases [J].
Morisseau, C ;
Goodrow, MH ;
Dowdy, D ;
Zheng, J ;
Greene, JF ;
Sanborn, JR ;
Hammock, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :8849-8854
[20]   Structural refinement of inhibitors of urea-based soluble epoxide hydrolases [J].
Morisseau, C ;
Goodrow, MH ;
Newman, JW ;
Wheelock, CE ;
Dowdy, DL ;
Hammock, BD .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (09) :1599-1608